Mary Schweitzer <marymsch@comcast.net> via Co-Cure Moderator to CO-CURE today
The CDC website for CFS is now marketing the Reeves questionnaires to clinicians to diagnose CFS.
The questionnaires were problematic when used as research, but researchers could still stick to the strict Fukuda definition or use another definition.
If they become the chief means of diagnosing patients with CFS, it will have a tremendous and unhappy consequence for the public and medical perception of the disease.
According to an article published by Leonard Jason, the CDC questionnaires create a data set that, when compared with one created using strict Fukuda, lop off the top 30% of the sickest patients - and that would mean leaving them with no diagnosis at all in the field.
In their place, the Reeves questionnaires fold in mainly patients with mood disorders such as mild depression or anxiety.
But since the Reeves questionnaires created an estimate of 4-7 million patients with CFS (as opposed to Jason's estimate, roughly one million today), the exchange is not at all equal.
The Reeves questionnaires would result in 6-10 patients with chronic fatigue (mainly due to mood disorders) diagnosed with CFS for every patient who would have been diagnosed using the Fukuda definition.
That means that 83.3-90% of patients seen by the public, by clinics, and by the media as having CFS would have "chronic fatigue" for reasons bearing no resemblance to the CFS diagnosis in the past.
Those of us with nothing but a CFS diagnosis (as much as we hate the term), would be left with either no diagnosis at all, or a diagnosis once again perceived - THANKS TO THE CDC - as wholly psychogenic.
The CDC mentions M.E. in passing as being distinct from CFS, but M.E. is not a recognized disease in the U.S. It is definitely not the default option for those who no longer meet the new CFS definition.
More to the point, when a longstanding CFS patient arrives at a hospital or a clinic with nothing but a CFS diagnosis, the likelihood will increase that those attending them will assume they have a psychiatric problem.
We had made some headway after years of such prejudice - now CDC is dragging us right back - not openly, but deceptively.
The danger to public health presented by this development cannot be emphasized strongly enough.
Something must be done.
I think it is worth noting that after CDC appeared to acquiesce in the unanimous request of CFS organizations in the US that Dr. Reeves be taken off our case, he's more present than ever. Elizabeth Unger and James Jones also share responsibility for this, as well as the somatization division of Emory University's Department of Psychiatry.
[No wonder so many patients identified by Reeves appear to have experienced some kind of abuse in childhood - they're not CFS-Fukuda patients at all.]
Mary M. Schweitzer
The CDC website for CFS is now marketing the Reeves questionnaires to clinicians to diagnose CFS.
The questionnaires were problematic when used as research, but researchers could still stick to the strict Fukuda definition or use another definition.
If they become the chief means of diagnosing patients with CFS, it will have a tremendous and unhappy consequence for the public and medical perception of the disease.
According to an article published by Leonard Jason, the CDC questionnaires create a data set that, when compared with one created using strict Fukuda, lop off the top 30% of the sickest patients - and that would mean leaving them with no diagnosis at all in the field.
In their place, the Reeves questionnaires fold in mainly patients with mood disorders such as mild depression or anxiety.
But since the Reeves questionnaires created an estimate of 4-7 million patients with CFS (as opposed to Jason's estimate, roughly one million today), the exchange is not at all equal.
The Reeves questionnaires would result in 6-10 patients with chronic fatigue (mainly due to mood disorders) diagnosed with CFS for every patient who would have been diagnosed using the Fukuda definition.
That means that 83.3-90% of patients seen by the public, by clinics, and by the media as having CFS would have "chronic fatigue" for reasons bearing no resemblance to the CFS diagnosis in the past.
Those of us with nothing but a CFS diagnosis (as much as we hate the term), would be left with either no diagnosis at all, or a diagnosis once again perceived - THANKS TO THE CDC - as wholly psychogenic.
The CDC mentions M.E. in passing as being distinct from CFS, but M.E. is not a recognized disease in the U.S. It is definitely not the default option for those who no longer meet the new CFS definition.
More to the point, when a longstanding CFS patient arrives at a hospital or a clinic with nothing but a CFS diagnosis, the likelihood will increase that those attending them will assume they have a psychiatric problem.
We had made some headway after years of such prejudice - now CDC is dragging us right back - not openly, but deceptively.
The danger to public health presented by this development cannot be emphasized strongly enough.
Something must be done.
I think it is worth noting that after CDC appeared to acquiesce in the unanimous request of CFS organizations in the US that Dr. Reeves be taken off our case, he's more present than ever. Elizabeth Unger and James Jones also share responsibility for this, as well as the somatization division of Emory University's Department of Psychiatry.
[No wonder so many patients identified by Reeves appear to have experienced some kind of abuse in childhood - they're not CFS-Fukuda patients at all.]
Mary M. Schweitzer